Advancing Prostate Cancer Diagnostics: A ConvNeXt Approach to Multi-Class Classification in Underrepresented Populations

Advancing Prostate Cancer Diagnostics: A ConvNeXt Approach to Multi-Class Classification in Underrepresented Populations

Blog Article

Prostate cancer is a leading cause of cancer-related morbidity and mortality worldwide, with diagnostic challenges magnified in underrepresented regions like sub-Saharan Africa.This study introduces a novel Hockey Sticks - Youth application of ConvNeXt, an advanced convolutional neural network architecture, for multi-class classification of prostate histopathological images into normal, benign, and malignant categories.The dataset, sourced from a tertiary healthcare institution in Nigeria, represents a typically underserved African population, addressing critical disparities in global diagnostic research.We also used the ProstateX dataset (2017) from The Cancer Imaging Archive (TCIA) to validate our result.A comprehensive pipeline was developed, leveraging advanced data augmentation, Grad-CAM for interpretability, and an ablation study to enhance model optimization and robustness.

The ConvNeXt model achieved an accuracy of 98%, surpassing the performance of traditional CNNs (ResNet50, 93%; EfficientNet, 94%; DenseNet, 92%) and transformer-based models (ViT, 88%; CaiT, 86%; Swin Transformer, 95%; RegNet, 94%).Also, using the ProstateX dataset, the ConvNeXt model recorded 87.2%, 85.7%, 86.4%, and 0.

92 as accuracy, recall, F1 score, and AUC, respectively, as validation results.Its hybrid architecture combines the strengths of CNNs and transformers, enabling superior feature extraction.Grad-CAM visualizations further enhance explainability, Ear Syringe bridging the gap between computational predictions and clinical trust.Ablation studies demonstrated the contributions of data augmentation, optimizer selection, and learning rate tuning to model performance, highlighting its robustness and adaptability for deployment in low-resource settings.This study advances equitable health care by addressing the lack of regional representation in diagnostic datasets and employing a clinically aligned three-class classification approach.

Combining high performance, interpretability, and scalability, this work establishes a foundation for future research on diverse and underrepresented populations, fostering global inclusivity in cancer diagnostics.